Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Current Assets:
Cash and equivalents	$ 2,348	$ 1,416
Restricted cash	46	65
Short-term investments	827	8
Trade receivables, net	2,559	2,534
Inventories:
Materials	777	714
Work in process	376	381
Finished products	2,076	2,178
Inventories	3,229	3,273
Prepaid expenses and other	1,330	1,380
Total Current Assets	10,340	8,676
Property, Plant and Equipment	13,925	13,578
Less allowances for depreciation and amortization	7,334	7,021
Property, Plant and Equipment, Net	6,591	6,557
Goodwill	24,566	24,522
Developed Technology, Net	7,538	8,058
Customer Relationships, Net	2,164	2,338
Other Intangibles, Net	558	552
Other Assets	2,399	2,078
Total Assets	54,157	52,780
Current Liabilities:
Current debt obligations	2,016	1,141
Payables, accrued expenses and other current liabilities	5,311	5,500
Total Current Liabilities	7,327	6,641
Long-Term Debt	15,995	14,738
Long-Term Employee Benefit Obligations	890	1,023
Deferred Income Taxes and Other Liabilities	4,297	4,582
Commitments and Contingencies (See Note 5)
Shareholders’ Equity
Common stock — $1 par value; authorized — 640,000,000 shares; issued — 370,594,401 shares in March 31, 2024 and September 30, 2023	371	371
Capital in excess of par value	19,795	19,720
Retained earnings	15,802	15,535
Deferred compensation	26	24
Treasury stock	(8,811)	(8,305)
Accumulated other comprehensive loss	(1,535)	(1,548)
Total Shareholders’ Equity	25,647	25,796
Total Liabilities and Shareholders’ Equity	$ 54,157	$ 52,780